"COMPARISON OF THERAPEUTIC EFFICACY OF MICRONEEDLING WITH PLATELET-RICH PLASMA PLUS 5% MINOXIDIL AND 5% MINOXIDIL ALONE IN ANDROGENETIC ALOPECIA"
Main Article Content
Keywords
Abstract
Background:
Alopecia, a complex dermatological condition, manifests through progressive follicular miniaturization and hair loss, adversely impacting psychological well-being and quality of life. Among its subtypes, androgenetic alopecia (AGA) is the most common form of nonscarring alopecia, largely influenced by genetic predisposition and androgen sensitivity. Despite therapeutic advancements, minoxidil and finasteride remain the only FDA-approved treatments, often limited by variable efficacy, prolonged use, and adverse effects. Platelet-rich plasma (PRP), an autologous biologic enriched with growth factors, has shown promise in hair restoration, although its protocols and long-term efficacy remain under investigation.
Aim and Objective:
To compare the therapeutic efficacy of 5% topical minoxidil monotherapy versus a multimodal regimen combining minoxidil, microneedling, and autologous PRP in the management of AGA.
Methods:
Fifty patients (aged 18–50 years) with AGA attending the Dermatology OPD at JMCH were enrolled and divided into Group A (minoxidil alone) and Group B (minoxidil + microneedling + PRP). PRP was administered monthly for six months. Microneedling was performed using a 1.5 mm dermaroller, followed by PRP injections and topical application. Efficacy was assessed via patient self-evaluation, standardized photographs, and Hamilton–Norwood grading at baseline, 3, and 6 months. Informed consent was obtained from all participants.
Results:
Mean ages were 30.04 years (Group A) and 31.12 years (Group B). Grade III alopecia (52%) was most prevalent. AGA had familial association in 54% of patients. Group B demonstrated significantly superior outcomes at 6 months (P < 0.05). Mild adverse effects included pruritus (16%), seborrheic dermatitis (14%), and headache (12%).
Conclusion:
The combination of minoxidil, microneedling, and PRP provides superior efficacy over monotherapy. PRP is a safe and effective adjunct, but standardized protocols and larger multicentric studies are warranted.
References
2. Sacchidanand S, Savitha AS, Shilpa K, Shashi Kumar BM, Nagesh TS. IADVL Textbook of Dermatology. 5th ed. Mumbai: Bhalani Publishing House; 2022. p. 1633-1766.
3. Hu R, Xu F, Han Y, et al. Trichoscopic findings of androgenetic alopecia and their association with disease severity. J Dermatol. 2015;42(6):602-7. doi:10.1111/1346-8138.12857.
4. Ntshingila S, Oputu O, Arowolo AT, Khumalo NP. Androgenetic alopecia: An update. JAAD Int. 2023 Jul 22;13:150-8. doi:10.1016/j.jdin.2023.07.005. PMID: 37823040; PMCID: PMC10562178.
5. Goren A, Naccarato T. Minoxidil in the treatment of androgenetic alopecia. Dermatol Ther. 2018;31(5):e12686. doi:10.1111/dth.12686.
6. Ruthvik S, John RS, George M, Kumar SP, Krishnan M. Comparison of efficacy of platelet-rich plasma with and without topical minoxidil for hair growth in patients with androgenetic alopecia: A prospective study. Cureus. 2024 Feb 8;16(2):e53875. doi:10.7759/cureus.53875. PMID: 38465061; PMCID: PMC10924654.
7. De Villez RL. Topical minoxidil therapy in hereditary androgenetic alopecia. Arch Dermatol. 1985;121:197–202. doi: 10.1001/archderm.121.2.197.
8. Muhammad A, Iftikhar N, Mashhood A, et al. Comparison of efficacy of platelet-rich plasma (PRP) with PRP microneedling in androgenetic alopecia. Cureus. 2022 Oct 18;14(10):e30418. doi:10.7759/cureus.30418. PMID: 36407242; PMCID: PMC9670661.
9. Faghihi G, Nabavinejad S, Mokhtari F, Fatemi Naeini F, Iraji F. Microneedling in androgenetic alopecia; comparing two different depths of microneedles. J Cosmet Dermatol. 2021 Apr;20(4):1241-7. doi:10.1111/jocd.13714.
10. Ocampo-Garza SS, Fabbrocini G, Ocampo-Candiani J, et al. Microneedling: A novel therapeutic approach for androgenetic alopecia. Dermatol Ther. 2020;33(6):e14267. doi:10.1111/dth.14267.
11. Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci. 1951;53(3):708-28. doi:10.1111/j.1749-6632.1951.tb31971.x.
12. Olsen E. Androgenetic alopecia. In: Disorders of Hair Growth: Diagnosis and Treatment. New York: McGraw-Hill; 1994. p. 257.
13. Williams DJ, Timothy GB, Dirk ME. Disorders of skin appendages. In: Andrew’s Diseases of the Skin: Clinical Dermatology. Philadelphia: Elsevier Inc; 2011. p. 741-7.
14. Smith MA, Wells RS. Male-type alopecia, alopecia areata, and normal hair in women; family histories. Arch Dermatol. 1964;89:95-8. doi:10.1001/archderm.1964.01590250101017.
15. Oiwoh SO, Enitan AO, Adegbosin OT, et al. Androgenetic alopecia: A review. Niger Postgrad Med J. 2024;31(2):85-92. doi:10.4103/npmj.npmj_47_24.
16. Enitan AO, Olasode OA, Onayemi OE, et al. Androgenetic alopecia: What impact does it have on the quality of life? Niger J Med. 2022;31:455-61.
17. Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: A community-based study in six cities. Br J Dermatol. 2010;162:843-7.
18. Shankar DK, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: Population-based study in 1,005 subjects. Int J Trichol. 2009;1:131-3.
19. Paik JH, Yoon JB, Sim WY, et al. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol. 2001;145:95-9.
20. Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg. 2001;27:53-4.
21. Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Invest Dermatol Symp Proc. 2005;10:184-9.
22. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341:491-7.
23. Pierard-Franchimont C, Pierard GE. Teloptosis, a turning point in hair shedding biorhythms. Dermatology. 2001;203:115-7.
24. Randall VA. The biology of androgenetic alopecia. In: Camacho F, Randall VA, Price VH, editors. Hair and its Disorders: Biology, Pathology and Management. London: Martin Dunitz; 2000. p. 123-36.
25. Roh C, Tao Q, Lyle S. Dermal papilla-induced hair differentiation of adult epithelial stem cells from human skin. Physiol Genomics. 2004;19:207-17.
26. Blanpain C, Lowry WE, Geoghegan A, et al. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:635-48.
27. Oshima H, Rochat A, Kedzia C, et al. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell. 2001;104:233-45.
28. Botchkarev VA, Kishimoto J. Molecular control of epithelial-mesenchymal interactions during hair follicle cycling. J Investig Dermatol Symp Proc. 2003;8:46-55.
29. Kishimoto J, Burgeson RE, Morgan BA. Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev. 2000;14:1181-5
30. Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin. 1996;14:697-711.
31. Randall VA. Androgens and human hair growth. Clin Endocrinol (Oxf). 1994;40(4):439-57.
32. Thornton MJ, Hamada K, Messenger AG, Randall VA. Beard, but not scalp, dermal papilla cells secrete autocrine growth factors in response to testosterone in vitro. J Invest Dermatol. 1998;111(5):727-32.
33. Randall VA, Thornton MJ, Messenger AG. Cultured dermal papilla cells from androgen-dependent human hair follicles (e.g. beard) contain more androgen receptors than those from non-balding areas of the scalp. J Endocrinol. 1992;133(1):141-7.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Harmeet Singh
Junior Resident , Department of Dermatology, Venereology and Leprosy, Jorhat Medical College and Hospital , Jorhat Assam
Dr. Krishna Talukdar
Professor and HOD, Department of Dermatology, Venereology and Leprosy Jorhat Medical College and Hospital, Jorhat, Assam
Dr. Minakshi Narah
Assistant professor, Department of Dermatology, Venereology and Leprosy Jorhat Medical College and Hospital, Jorhat, Assam
Dr. Balu Haridas
Junior Resident , Department of Dermatology, Venereology and Leprosy, Jorhat Medical College and Hospital , Jorhat Assam
Dr. Porimollika Boruah
Senior resident, Department of Dermatology, Venereology and Leprosy Tinsukia Medical College and Hospital, Jorhat, Assam
Dr. Aparajita Roy
Senior resident Department of Dermatology, Venereology and Leprosy Lakhimpur Medical College and Hospital, Jorhat, Assam
Dr. Pallabi Hatikakoty
Junior Resident, Department of Dermatology, Venereology and Leprosy, Jorhat Medical College and Hospital, Jorhat Assam